Sandoz’s Saynor: ‘Everyone’s Asking The Wrong Questions’ On GLP-1s

CEO Points To Manufacturing Capacity, Not Size Of Market, As Key Consideration

Many unknowns remain when it comes to the generic GLP-1 opportunity (Shutterstock)

More from Generics

More from Products